Jump to content

User:Tinarss/Estrone/progesterone

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Futurepharmd (talk | contribs) at 23:27, 27 July 2023 (Added a citation). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

We plan to separate the combination medication and address the following: side effects, adverse effects, contraindications, indications, availability, and pricing.

role in pediatrics

Amenorrhea

is the absence of one or more menstrual periods. [1]

Estrone:

[2]

Side Effects:

Adverse Effects:

Contraindications:

Indications:

Availability:

Pricing

Progesterone:

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

Side Effects:

Adverse Effects:

Contraindications:

Indications:

Availability:

Pricing:

Article Draft

Lead

Article body

References

  1. ^ King, Elizabeth M.; Albert, Arianne Y.; Murray, Melanie C.M. (2019-03-01). "HIV and amenorrhea: a meta-analysis". AIDS. 33 (3): 483–491. doi:10.1097/QAD.0000000000002084. ISSN 0269-9370.
  2. ^ academic.oup.com https://academic.oup.com/crawlprevention/governor?content=%2fjcem%2farticle%2f100%2f11%2f4021%2f2836077. Retrieved 2023-07-26. {{cite web}}: Missing or empty |title= (help)
  3. ^ Jarde, A; Lutsiv, O; Beyene, J; McDonald, Sd (2019-04). "Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis". BJOG: An International Journal of Obstetrics & Gynaecology. 126 (5): 556–567. doi:10.1111/1471-0528.15566. {{cite journal}}: Check date values in: |date= (help)
  4. ^ Stewart, Lesley A; Simmonds, Mark; Duley, Lelia; Llewellyn, Alexis; Sharif, Sahar; Walker, Ruth AE; Beresford, Lucy; Wright, Kath; Aboulghar, Mona M; Alfirevic, Zarko; Azargoon, Azam; Bagga, Rashmi; Bahrami, Elham; Blackwell, Sean C; Caritis, Steve N (2021-03). "Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials". The Lancet. 397 (10280): 1183–1194. doi:10.1016/s0140-6736(21)00217-8. ISSN 0140-6736. {{cite journal}}: Check date values in: |date= (help)
  5. ^ Care, Angharad; Nevitt, Sarah J; Medley, Nancy; Donegan, Sarah; Good, Laura; Hampson, Lynn; Tudur Smith, Catrin; Alfirevic, Zarko (2022-02-15). "Interventions to prevent spontaneous preterm birth in women with singleton pregnancy who are at high risk: systematic review and network meta-analysis". BMJ: e064547. doi:10.1136/bmj-2021-064547. ISSN 1756-1833. PMC 8845039. PMID 35168930.{{cite journal}}: CS1 maint: PMC format (link)
  6. ^ Lipman, Zoe M.; Labib, Angelina; Vander Does, Ashley; Yosipovitch, Gil (2022). "Autoimmune Progesterone Dermatitis: A Systematic Review". Dermatitis. 33 (4): 249–256. doi:10.1097/DER.0000000000000779. ISSN 2162-5220.
  7. ^ Kaemmle, L. M.; Stadler, A.; Janka, H.; von Wolff, M.; Stute, P. (2022). "The impact of micronized progesterone on cardiovascular events – a systematic review". Climacteric. 25 (4): 327–336. doi:10.1080/13697137.2021.2022644. ISSN 1369-7137.
  8. ^ Javed, Ayesha A.; Mayhew, Alexandra J.; Shea, Alison K.; Raina, Parminder (2019). "Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic Review and Meta-analysis". JAMA Network Open. 2 (8): e1910154. doi:10.1001/jamanetworkopen.2019.10154. ISSN 2574-3805. PMC 6716293. PMID 31461147.{{cite journal}}: CS1 maint: PMC format (link)
  9. ^ Coquoz, A.; Gruetter, C.; Stute, P. (2019). "Impact of micronized progesterone on body weight, body mass index, and glucose metabolism: a systematic review". Climacteric. 22 (2): 148–161. doi:10.1080/13697137.2018.1514003. ISSN 1369-7137.
  10. ^ Gasser, S.; Heidemeyer, K.; von Wolff, M.; Stute, P. (2021). "Impact of progesterone on skin and hair in menopause – a comprehensive review". Climacteric. 24 (3): 229–235. doi:10.1080/13697137.2020.1838476. ISSN 1369-7137.
  11. ^ Dolitsky, Shelley N.; Cordeiro Mitchell, Christina N.; Stadler, Sarah Sheehan; Segars, James H. (2021). "Efficacy of progestin-only treatment for the management of menopausal symptoms: a systematic review". Menopause. 28 (2): 217–224. doi:10.1097/GME.0000000000001676. ISSN 1530-0374.